FDA Inspection 819155 — Qingdao Kangyuan Pharmaceutical Co. Ltd.
The FDA completed an inspection of Qingdao Kangyuan Pharmaceutical Co. Ltd. on Jan 25, 2013 in Qingdao. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 25, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qingdao (China)